Winzap, Patric
Davies, Allan http://orcid.org/0000-0002-5929-3472
Klingenberg, Roland
Obeid, Slayman
Roffi, Marco
Mach, François
Räber, Lorenz
Windecker, Stephan
Templin, Christian
Nietlispach, Fabian
Nanchen, David
Gencer, Baris
Muller, Olivier
Matter, Christian M.
von Eckardstein, Arnold
Lüscher, Thomas F.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications
https://doi.org/10.1371/journal.pone.0093147
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61
https://doi.org/10.1186/s12933-019-0946-6
Article History
Received: 18 August 2019
Accepted: 11 October 2019
First Online: 31 October 2019
Ethics approval and consent to participate
: The study was approved by the local ethical committees and all patients gave written informed consent in compliance with the Declaration of Helsinki, and it is listed at ClinicalTrials.gov (NCT 01000701).
: Not applicable.
: MR has received institutional research grants from Abbott Vascular, Boston Scientific, Terumo, Medtronic, and Biotronik; RK has received advisory board fees from Novartis; FM has received research grants to the institution from Amgen, AstraZeneca, Boston Scientific, Biotronik, Medtronic, MSD, Eli Lilly and St. Jude Medical including speaker or consultant fees; LR received speaker fees and research grants to the institution from St. Jude Medical; SW has received research grants to the institution from Abbott, Boston Scientific, Biosensors, Biotronik, the Medicines Company, Medtronic and St. Jude Medical and honoraria from Abbott, Astra Zeneca, Eli Lilly, Boston Scientific, Biosensors, Biotronik, Medtronic and Edwards; FN is serving as a consultant for Abbott, Edwards Lifesciences and Medtronic; AvE received speaker or consultant fees from Amgen, MSD, and Sanofi-Aventis; TFL received research grants to the institution from AstraZeneca, Bayer Healthcare, Biosensors, Biotronik, Boston Scientific, Eli Lilly, Medtronic, MSD, Merck, Roche and Servier, including speaker fees by some of them. CMM received research grants to the institution from Eli Lilly, AstraZeneca, Roche, Amgen and MSD including speaker or consultant fees.